featured
Irinotecan Plus Capecitabine Is Not Superior to Capecitabine Monotherapy in Patients With MBC Previously Treated with Anthracycline and Taxane
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cancer Research and Treatment: Official Journal of Korean Cancer Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine Versus Capecitabine Monotherapy in Patients With Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)
Cancer Res Treat 2018 Feb 14;[EPub Ahead of Print], IH Park, SA Im, KH Jung, JH Sohn, YH Park, KS Lee, SH Sim, KH Park, JH Kim, BH Nam, HJ Kim, TY Kim, KH Lee, SB Kim, JH Ahn, S Lee, J RoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.